Endothelin-1 improves the impaired filterability of red blood cells through the activation of protein kinase C

Japanese Journal of Physiology

Volumn 49, Issue 1, 1999, Pages 113-120

  Sakashita, Kanako ^a   Oonishi, Tadahiro ^a   Ishioka, Noriaki ^b   Uyesaka, Nobuhiro ^c  

^a NTT CORPORATION   (Japan)

^b JAPAN AEROSPACE EXPLORATION AGENCY   (Japan)

^c NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Deformability; Endothelin 1; Human red blood cells; Mechanical stress; Protein kinase C

Indexed keywords

CALCIUM; CALPHOSTIN C; CYCLIC AMP DEPENDENT PROTEIN KINASE; ENDOTHELIN 1; ENDOTHELIN RECEPTOR AGONIST; MEMBRANE PROTEIN; PROTEIN KINASE C; PROTEIN KINASE INHIBITOR; SUCCINYLENDOTHELIN 1 [8-21][9 GLUTAMIC ACID 11,15 ALANINE];

ARTICLE; BLOOD FILTRATION; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL SHAPE; ENZYME ACTIVATION; ERYTHROCYTE; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTE MEMBRANE; FILTRATION; HUMAN; HUMAN CELL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 0032933474     PISSN: 0021521X     EISSN: None     Source Type: Journal    
DOI: 10.2170/jjphysiol.49.113     Document Type: Article

References (33)

1. Chien S: Red cell deformability and its relevance to blood flow. Annu Rev Physiol 49: 177-192, 1987
2. Aral K, Iino M, Shio H, and Uyesaka N: Further investigation of red cell deformability with nickel mesh. Biorheology 27: 47-65, 1990
3. Cohen CM and Gascard P: Regulation and post-translational modification of erythrocyte membrane and membrane-skeletal proteins. Semin Hematol 29: 244-292, 1992
4. Uyesaka N, Hasegawa S, Ishioka N, Ishioka R, Shio H, and Schechter AN: Effect of superoxide anions on red cell deformability and membrane proteins. Biorheology 29: 217-229, 1992
5. Mohandas N and Chasis JA: Red cell deformability, membrane material properties and shape: regulation by transmembrane, skeletal and cytosolic proteins and lipids. Semin Hematol 30: 171-192, 1993
6. Rodgers GP, Dover GJ, Uyesaka N, Noguchi CT, Schechter AN, and Nienhuis AW: Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease. N Engl J Med 328: 73-80, 1993
7. Nakamura T, Hasegawa S, Shio H, and Uyesaka N: Rheologic and pathophysiologic significance of red cell passage through narrow pores. Blood Cells 20: 151-165, 1994
8. Hiruma H, Noguchi CT, Uyesaka N, Schechter AN, and Rodgers GP: Contributions of sickle hemoglobin polymer and cell membranes to impaired filterability. Am J Physiol 268: H2003-H2008, 1995
9. 2+ influx and cAMP-mediated signaling pathways. Am J Physiol 273: C1828-C1834, 1997
10. Haynes W and Webb DJ: The endothelin family of peptides: local hormones with diverse roles in health and disease? Clin Sci 84: 485-500, 1993
11. Yano T, Taura C, Shibata M, Hirono Y, Ando S, Kusubata M, Takahashi T, and Inagaki M: A monoclonal antibody to phosphorylated form of glial fibrillary acidic protein: application to a non-radioactive method for measuring protein kinase activities. Biochem Biophys Res Commun 175: 1144-1151, 1991
12. Kobayashi E, Nakano H, Morimoto M, and Tamaoki T: Calphostin C (UCN-1208C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 159: 548-553, 1989
13. 11.15]-endothelin-1(8-21), IRL 1620 for the ETB receptor. Biochem Biophys Res Commun 184: 953-959, 1992
14. Kuwluru R, Bitensky MW, Kuwluru A, Dembo M, Keaton PA, and Buican T: Reversible sodium pump defect and swelling in the diabetic rat erythrocyte: effects on filterability and implications for microangiopathy. Proc Natl Acad Sci USA 86: 3327-3331, 1989
15. 2+ pump activity by protein kinase C. J Biol Chem 263 2195-2202, 1988
16. 2--ATPase by protein kinase C in intact human erythrocytes. Arch Biochem Biophys 306: 277-284, 1993
17. Ramachandran M and Abraham EC: Age-dependent variation in the cytosol/membrane distribution of red cell protein kinase-C. Am J Hematol 31: 69-70, 1989
18. Jindal H, Ai KZ, Gascard P, Horton C, and Cohen CM: Specific loss of protein kinase activities in senescent erythrocytes. Blood 88: 1479-1487, 1996
19. Kundu M, Basu J, Fujimagari M, Williamson P, Schlegel RA, and Chakrabarti P: Altered erythrocyte protein kinase C activity and membrane protein phosphorylation in chronic myelogenous leukemia. Biochim Biophys Acta 1096: 205-208, 1991
20. Kravtsov GM, Dulin NO, and Postnov YV: Activity of protein kinase C in erythrocytes in primary hypertension. J Hypertens 6: 853-857, 1988
21. Ramachandran M, Nair CN, and Abraham EC: Increased membrane-associated phorbol-12,13 dibutyrate (PDBu) receptor function in sickle red cells. Biochem Biophys Res Commun 147: 56-64, 1987
22. Apovo M, Gascard P Rhoda MD, Beuzard Y, and Girau F: Alteration in protein kinase C activity and subcellular distribution in sickle erythrocytes. Biochim Biophys Acta 984: 26-32, 1989
23. Fathallah H, Coezy E, René-Serge de Neef, Hardy-Dessources M-D, and Giraud F: Inhibition of deoxygeneration-induced membrane protein dephosphorylation and cell dehydration by phorbol esters and okadaic acid in sickle cells. Blood 86: 1999-2007, 1995
24. 2+-dependent phosphorylation of human red blood cell membrane skeletal proteins. J Biol Chem 261: 7701-7709, 1986
25. Danilov YN and Cohen CM: Wheat germ agglutinin but not concanavalin A modulates protein kinase C-mediated phosphorylation of red cell skeletal proteins. FEBS Lett 257: 431-434, 1989
26. Matsuoka Y, Hughes CA, and Bennett V: Adducin regulation. Definition of the calmodulin-binding domain and sites of phosphorylation by protein kinases A and C. J Biol Chem 271: 25157-25166, 1996
27. Palfrey HC and Waseem A: Protein kinase C in the human erythrocyte. J Biol Chem 258: 14069-14073, 1985
28. Palfrey HC and Waseem A: Protein kinase C and its associated substrates in the human erythrocyte. Soc Gen Physiol Ser 43: 357-369, 1988
29. 2 by adult human red blood cells. Prostaglandin Other Lipid Mediat 56: 89-101, 1998
30. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, and Masaki T: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415, 1988
31. B receptor. Am J Physiol 264: R777-R783, 1993
32. Hashido K, Gamou T, Adachi M, Tabuchi H, Watanabe T, Furuichi Y, and Miyamoto C: Truncation of N-terminal extracellular domains of human ETA receptor abrogated the binding activity to ET-1. Biochem Biophys Res Commun 187: 1241-1248, 1992
33. Minetti G and Low PS: Erythrocyte signal transduction pathways and their possible functions. Curr Opin Hematol 4: 116-121, 1997